Coco Kou
Financieel Directeur/CFO bij QHY GROUP
Actieve functies van Coco Kou
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| QHY GROUP | Financieel Directeur/CFO | - | - |
| Comptroller/Controller/Auditor | - | - | |
| FOUR LEAF ACQUISITION CORPORATION | Financieel Directeur/CFO | 01-01-2022 | - |
Loopbaan van Coco Kou
Eerdere bekende functies van Coco Kou
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| XYNOMIC PHARMACEUTICALS HOLDINGS, INC. | Financieel Directeur/CFO | 01-01-2019 | 01-01-2021 |
Salion Food Condiment Co., Ltd.
 Salion Food Condiment Co., Ltd. Food: Major DiversifiedConsumer Non-Durables Salion Food Condiment Co., Ltd. engages in the manufacture of compound condiment products in Northern China. It operates through the following geographical segments: Mainland China, Singapore, Korea, Russia, Europe, and Others. The company was founded on August 23, 2016 and is headquartered in Beijing, China. | Financieel Directeur/CFO | 01-01-2017 | 01-01-2018 |
Opleiding van Coco Kou
| Peking University | Graduate Degree |
| University of Hong Kong | Masters Business Admin |
| London Business School | Masters Business Admin |
| Columbia Business School | Masters Business Admin |
Statistieken
Internationaal
| Verenigde Staten | 4 |
| China | 3 |
| Hongkong | 2 |
Operationeel
| Director of Finance/CFO | 4 |
| Masters Business Admin | 3 |
| Comptroller/Controller/Auditor | 1 |
Sectoraal
| Consumer Services | 5 |
| Industrial Services | 2 |
| Consumer Non-Durables | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| QHY GROUP | Industrial Services |
| FOUR LEAF ACQUISITION CORPORATION | Finance |
| Bedrijven in privébezit | 2 |
|---|---|
Salion Food Condiment Co., Ltd.
Salion Food Condiment Co., Ltd. Food: Major DiversifiedConsumer Non-Durables Salion Food Condiment Co., Ltd. engages in the manufacture of compound condiment products in Northern China. It operates through the following geographical segments: Mainland China, Singapore, Korea, Russia, Europe, and Others. The company was founded on August 23, 2016 and is headquartered in Beijing, China. | Consumer Non-Durables |
Xynomic Pharmaceuticals Holdings, Inc.
 Xynomic Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Xynomic Pharmaceuticals Holdings, Inc. is a clinical stage best-in-class oncology therapeutics biopharmaceutical company. It engages in licensing, developing and commercializing oncology drug candidates in China, US, and rest of the world. Its current pipeline mainly consists of 3 drug candidates; Xynomic owns global exclusive development, manufacturing and commercialization rights to each of these. Its lead drug candidate abexinostat is in global potentially pivotal clinical trials against renal cell carcinoma and non-Hodgkin's lymphoma. The company was founded by Yinglin Mark Xu on October 7, 2016 and is headquartered in Shanghai, China. | Health Technology |
